No Picture
News

Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients

– Randomized, placebo-controlled 12-week study showed mean liver fat reduction of up to 55% with MET409- 93% of patients showed liver fat reduction of at least 30% from baseline

SAN DIEGO, Jan. 22, 2020 /PRNewswire/ — Metacrine, Inc., a clinical-sta… […]

No Picture
News

Denovo Biopharma Enters into Option Agreement with Rumpus Therapeutics for Selected DB102 (Enzastaurin) Clinical Indications

– Broadens Development of DB102 Beyond Oncology and PAH- Monetizes DB102 Prior to ENGINE Data Read-out

SAN DIEGO, Jan. 21, 2020 /PRNewswire/ — Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today anno… […]

No Picture
News

Trovagene to Present New Clinical Data for Onvansertib in Metastatic KRAS-Mutated Colorectal Cancer at ASCO 2020 Gastrointestinal Cancers Symposium

SAN DIEGO, Jan. 21, 2020 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing onvansertib for the treatment of various cancers including colorectal, prostate and leukemia, today announced that a… […]

No Picture
News

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2019 Financial Results

Conference Call and Webcast Scheduled for Tuesday, February 4

SAN DIEGO, Jan. 20, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2019 financial results after the Nasdaq… […]

No Picture
News

FDA Grants Fast Track Designation to Arena Pharmaceuticals’ APD418 for Development in Decompensated Heart Failure Patients

– APD418 currently in Phase 1 clinical investigation – data expected this year

SAN DIEGO, Jan. 16, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track des… […]

No Picture
News

Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions

— Exclusive license option grants Bloom rights to intellectual property for genetic manipulation and extensive strain library of Akkermansia bacteria —

SAN DIEGO, Jan. 15, 2020 /PRNewswire/ — Bloom Science, a biopharmaceutical company focused on … […]

No Picture
News

Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary

SAN DIEGO, Jan. 13, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today the appointment of Joan Schmidt as Executive Vice President, General Counsel and Secretary. Ms. Schmidt will join Arena formally in March 20… […]

No Picture
News

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.

SAN DIEGO, Jan. 9, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands a… […]